Literature DB >> 6363174

The crystal structures of three non-pancreatic human insulins.

S A Chawdhury, E J Dodson, G G Dodson, C D Reynolds, S P Tolley, T L Blundell, A Cleasby, J E Pitts, I J Tickle, S P Wood.   

Abstract

X-ray studies on semi-synthetic human insulin have shown that it crystallizes in the rhombohedral space group R3 and is nearly isomorphous with 2 Zn pig insulin. Precession photographs of crystals of human and pig insulins show observable changes in the intensity patterns. Crystallographic analysis and refinement of semi-synthetic human insulin at 1.9 A resolution have shown that its molecular structure is very like that of pig insulin except at the C-terminus of the B chain where the change in sequence occurs. We also report the results of a high resolution crystallographic study of human insulins from different origins. The X-ray diffraction patterns of three non-pancreatic human insulins are indistinguishable from each other and from pancreatic human insulin. Refinement of the structures of the non-pancreatic human insulins has shown that they are identical within the limits of experimental error.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6363174     DOI: 10.1007/bf00284451

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  7 in total

1.  Expression in Escherichia coli of chemically synthesized genes for human insulin.

Authors:  D V Goeddel; D G Kleid; F Bolivar; H L Heyneker; D G Yansura; R Crea; T Hirose; A Kraszewski; K Itakura; A D Riggs
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

Review 2.  Human insulin.

Authors:  P D Home; K G Alberti
Journal:  Clin Endocrinol Metab       Date:  1982-07

3.  Structural relationships in the two-zinc insulin hexamer.

Authors:  E J Dodson; G G Dodson; D C Hodgkin; C D Reynolds
Journal:  Can J Biochem       Date:  1979-06

4.  Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patients.

Authors:  A J Clark; R O Adeniyi-Jones; G Knight; J M Leiper; P G Wiles; R H Jones; H Keen; A C MacCuish; J D Ward; P J Watkins; J M Cauldwell; A Glynne; J B Scotton
Journal:  Lancet       Date:  1982-08-14       Impact factor: 79.321

5.  Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin.

Authors:  F W Kemmer; G Sonnenberg; H J Cüppers; M Berger
Journal:  Diabetes Care       Date:  1982 Nov-Dec       Impact factor: 19.112

6.  Human and porcine regular insulins are equally effective in subcutaneous replacement therapy. Results of a double-blind crossover study in type I diabetic patients with continuous subcutaneous insulin infusion.

Authors:  G E Sonnenberg; E Chantelau; S Sundermann; C Hauff; M Berger
Journal:  Diabetes       Date:  1982-07       Impact factor: 9.461

7.  Chemical, physical, and biologic properties of biosynthetic human insulin.

Authors:  R E Chance; E P Kroeff; J A Hoffmann; B H Frank
Journal:  Diabetes Care       Date:  1981 Mar-Apr       Impact factor: 19.112

  7 in total
  3 in total

1.  Human insulin.

Authors:  J Pickup
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-18

Review 2.  Human insulin: much ado about one amino acid?

Authors:  G E Sonnenberg; M Berger
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

3.  Structural stability in the 4-zinc human insulin hexamer.

Authors:  G D Smith; D C Swenson; E J Dodson; G G Dodson; C D Reynolds
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.